FOXA1 and fatty liver disease: An earlier study found that FOXA1 reduced steatosis in primary cultured hepatocytes and HepG2, and the expression of FOXA1 was downregulated in both murine models of hepatic steatosis and in human steatotic liver tissue [52,53].